Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Management to Present at Upcoming Investor Conferences Sep 03, 2024 Nektar Therapeutics Reports Second Quarter 2024 Financial Results Aug 08, 2024 Nektar to Announce Financial Results for the Second Quarter 2024 on Thursday, August 8, 2024, After Close of U.S.-Based Financial Markets Aug 01, 2024 Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024 Jun 12, 2024 Nektar Management to Present at Upcoming Investor Conferences May 30, 2024 Nektar Therapeutics Reports First Quarter 2024 Financial Results May 09, 2024 Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets May 02, 2024 Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference Mar 22, 2024 Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata Mar 05, 2024 Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results Mar 04, 2024 Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »